首页> 外文OA文献 >Apheresis Therapy for Prolonged Red Cell Aplasia after Major ABO-Mismatched Bone Marrow Transplantation
【2h】

Apheresis Therapy for Prolonged Red Cell Aplasia after Major ABO-Mismatched Bone Marrow Transplantation

机译:apheresis Therapy for prolonged Red Cell aplasia after major aBO-mismatched Bone marrow Transplantation

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two cases of leukemia were treated successfully with apheresis for delayed recovery of erythropoiesis due to antibody-mediated red cell aplasia after ABO-mismatched bone marrow transplantation (BMT). A 25-year-old female (ABO group O) underwent BMT from her brother (group A). Immunoadsorption using Biosynsorb A performed on day 146 after BMT followed by double filtration plasma pheresis (DFPP) reduced anti-A antibody titers from 1:32 to 1:2. Anemia improved dramatically within 2 weeks. A 49-year-old female (group O) underwent BMT from her mother (group A). She was treated with DFPP on day 131 after BMT. Anti-A antibody titers dropped from 1:16 to 1:1 and anemia improved gradually.
机译:ABO不匹配的骨髓移植(BMT)后,由于抗体介导的红细胞发育不全,使两例白血病成功通过单采术治疗,延迟了红细胞生成的恢复。一名25岁的女性(ABO组O)从她的兄弟(A组)接受了BMT。 BMT后第146天使用Biosynsorb A进行免疫吸附,然后进行两次血浆过滤血浆分离(DFPP),将抗A抗体的滴度从1:32降低至1:2。 2周内贫血显着改善。一名49岁的女性(O组)接受了来自母亲(A组)的BMT。 BMT后第131天接受DFPP治疗。抗A抗体滴度从1:16降至1:1,贫血逐渐改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号